Clinical Trial Update: Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

View source ↗

Summary

This update reports the completion of a replication trial evaluating TRF-budesonide for IgA nephropathy. The results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• TRF-budesonide (budesonide)

Snippet

Sponsor: Ruijin Hospital | Conditions: Primary IgA Nephropathy | Status: COMPLETED